2Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease - a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention [J]. Circulation, 2007. 115: 2761-2788.
3Stump CS, Hamilton MT, Sowers JR. Effect of antibypertensive agents on the development of type 2 diabetes mellitus [J]. Mayo Clin Proc,2006, 81: 1637-1638.
4Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence [J]. Diabetes Care, 2008,31: 1898-1904.
5Christogiannis LG , Kostapanos MS , Teilis CC, et al. Distinct effects of fixed combinations of vaisartan with either amiodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension. J Hum Hypertens. 2011. doi: 10.1038/ jhh.2011.108.
6Eriksson JW, Jansson PA, Carlberg B.Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study [J]. Hypertension, 2008,Dec 52(6): 1030-1037.
7Cooper-DeHoff RM, Wen S, Beitelshees AL, et al. Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications [J]. Hypertension,2010; 55: 61-68.
8Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) [J]. J Hypertens,2000, 18: 1149-1154.
9Elliot WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis [J]. Lancet,2007,369: 201-207.
10Gustafson B, Hammarstedt A, Andersson CX, et al. Inflamed adipose tissue - a culprit underlying the metabolic syndrome and atheroselerosis [J]. Arterioseler Thromb Vase Biol, 2007, 27: 2276-2283.
8KIM M D, HYUN D, BLEYS M D, et al. Risk of ischemic stroke associated with low-dose oral contraceptive use: a meta- analysis[J]. The Medicine Forum, 2011,7(1):21.
9CHAKHTOURA Z, CANONICO M, GOMPEL A, et al. Progestogen-only contraceptives and the risk of stroke a Meta- analysis[J]. Stroke, 2009,40(4) :1059-1062.
10NEWCOMER J W. Metabolic considerations in the use of anti- psychotic medications: a review of recent evidence [J]. The Journal of Clinical Psychiatry, 2007,68 : 20 27.
